Atypowa hiperplazja piersi
Charakterystyka, pielęgnacja i opieka
Atypowa hiperplazja piersi (AH) to stan przedrakowy charakteryzujący się nieprawidłowym rozrostem komórek w tkance piersiowej, zwiększający ryzyko rozwoju raka piersi około czterokrotnie w porównaniu do populacji ogólnej. Wyróżnia się dwa główne typy AH: atypową hiperplazję przewodową (ADH) i zrazikową (ALH). Diagnostyka opiera się na badaniach obrazowych (mammografia, USG) oraz biopsji igłowej, a w przypadku wykrycia AH często zaleca się biopsję chirurgiczną w celu wykluczenia obecności raka in situ lub inwazyjnego, które stwierdza się w 10-20% przypadków. Leczenie obejmuje wycięcie zmiany (biopsja wycinająca lub vacuum-assisted biopsy) oraz farmakoterapię blokującą estrogen (SERM: tamoksyfen, raloksyfen; inhibitory aromatazy: anastrozol, letrozol, eksemestan), co może zmniejszyć ryzyko raka piersi nawet o 86%. Monitorowanie pacjentek powinno obejmować badania kliniczne co 6-12 miesięcy, coroczną mammografię z tomosyntezą oraz rozważenie MRI piersi, szczególnie u kobiet z wysokim ryzykiem (>20% ryzyka inwazyjnego raka w ciągu życia).
- Definicja atypowej hiperplazji piersi
- Diagnostyka atypowej hiperplazji piersi
- Leczenie atypowej hiperplazji piersi
- Monitorowanie i badania kontrolne
- Strategie zmniejszenia ryzyka raka piersi
- Wsparcie psychologiczne i edukacja pacjentki
- Opieka interdyscyplinarna
- Rokowanie i perspektywy długoterminowe
- Wnioski i zalecenia dla praktyki pielęgniarskiej
Definicja atypowej hiperplazji piersi
Atypowa hiperplazja piersi (atypical hyperplasia of the breast) to stan przedrakowy charakteryzujący się nieprawidłowym rozwojem komórek w tkance piersiowej. Powoduje nagromadzenie komórek, które pod mikroskopem wyglądają inaczej niż typowe komórki piersi. Chociaż atypowa hiperplazja nie jest rakiem piersi, stanowi istotny czynnik ryzyka jego rozwoju w przyszłości. Ryzyko wystąpienia raka piersi u osób z atypową hiperplazją jest około czterokrotnie wyższe niż u osób bez tego schorzenia.123
Atypową hiperplazję piersi dzielimy na dwa główne typy:1
- Atypowa hiperplazja przewodowa (atypical ductal hyperplasia, ADH) – dotyczy nieprawidłowego wzrostu komórek w przewodach mlecznych piersi. Jest to najczęstszy typ atypowej hiperplazji.
- Atypowa hiperplazja zrazikowa (atypical lobular hyperplasia, ALH) – obejmuje nieprawidłowy wzrost komórek w zrazikach piersi, czyli gruczołach produkujących mleko. Ten typ występuje rzadziej.
Oba typy atypowej hiperplazji zwiększają ryzyko raka piersi i podobnie się je leczy.12
Diagnostyka atypowej hiperplazji piersi
Atypowa hiperplazja piersi zwykle nie powoduje żadnych objawów i zazwyczaj jest wykrywana podczas biopsji piersi. Biopsja jest wykonywana w celu zbadania niepokojących zmian zauważonych podczas badań obrazowych, takich jak mammografia, lub w celu diagnostyki wyczuwalnego guza.11
Proces diagnostyczny obejmuje:12
- Badanie mammograficzne lub USG piersi, które może ujawnić podejrzane obszary
- Biopsja igłowa kierowana obrazem w celu pobrania próbki tkanki
- Ocena histopatologiczna pobranego materiału
Jeśli w biopsji igłowej zostanie zdiagnozowana atypowa hiperplazja, lekarz może zalecić wykonanie biopsji chirurgicznej (biopsji wycinającej) w celu usunięcia większej próbki tkanki i zbadania jej pod kątem obecności komórek nowotworowych. Jest to ważne, ponieważ w około 10-20% przypadków atypowej hiperplazji wykrytej w biopsji igłowej, po wykonaniu szerszej biopsji chirurgicznej, znajduje się raka in situ lub inwazyjnego.12
Opieka pielęgniarska w procesie diagnostycznym
Rola pielęgniarki w procesie diagnostycznym atypowej hiperplazji piersi obejmuje:1
- Edukację pacjentki odnośnie procedury biopsji i przygotowanie jej do zabiegu
- Monitorowanie stanu pacjentki podczas i po biopsji
- Udzielanie wsparcia emocjonalnego i informacyjnego
- Pomoc w zrozumieniu diagnozy i planowaniu dalszej opieki
- Instruktaż dotyczący pielęgnacji miejsca po biopsji
Leczenie atypowej hiperplazji piersi
Leczenie atypowej hiperplazji piersi ma na celu usunięcie nieprawidłowych komórek oraz zmniejszenie ryzyka rozwoju raka piersi w przyszłości. Plan leczenia jest indywidualnie dostosowany do każdej pacjentki, z uwzględnieniem jej stanu zdrowia, wyników badań oraz osobistego ryzyka zachorowania na raka piersi.12
Leczenie chirurgiczne
Leczenie chirurgiczne atypowej hiperplazji piersi może obejmować:123
- Wycięcie zmiany – standardowe podejście, szczególnie w przypadku atypowej hiperplazji przewodowej (ADH) wykrytej w biopsji gruboigłowej
- Biopsja wycinająca – usunięcie większego fragmentu tkanki piersi z obszaru, gdzie wykryto atypowe komórki
- Biopsja wspomagana próżnią (vacuum-assisted biopsy) – nowsza, mniej inwazyjna metoda usuwania zmian
Należy podkreślić, że nie każda pacjentka z atypową hiperplazją wymaga leczenia chirurgicznego. Decyzja o leczeniu operacyjnym jest podejmowana na podstawie oceny wyników badań obrazowych, wyników biopsji oraz innych czynników, takich jak wywiad medyczny i przebyte operacje piersi.13
Tkanka usunięta podczas zabiegu jest badana pod kątem obecności komórek rakowych. U większości osób poddanych operacji z powodu atypowej hiperplazji nie stwierdza się raka piersi. Jednak czasami w trakcie zabiegu wykrywa się raka nieinwazyjnego (carcinoma in situ) lub inwazyjnego.3
Farmakoterapia
W celu zmniejszenia ryzyka rozwoju raka piersi u pacjentek z atypową hiperplazją stosuje się leki blokujące działanie estrogenu w organizmie. Większość nowotworów piersi wykorzystuje estrogen i inne hormony do wzrostu, dlatego blokowanie estrogenu pomaga zapobiegać powstawaniu raka.12
Najczęściej stosowane leki obejmują:123
- Selektywne modulatory receptora estrogenowego (SERM) – tamoksyfen i raloksyfen
- Działają poprzez blokowanie efektów działania estrogenu w tkance piersi
- Mogą zmniejszyć ryzyko raka piersi nawet o 86% u kobiet z atypową hiperplazją
- Są przyjmowane doustnie w formie tabletek
- Inhibitory aromatazy – anastrozol, letrozol, eksemestan
- Blokują działanie enzymu aromatazy, który przekształca inne hormony w estrogen
- Zazwyczaj zalecane kobietom po menopauzie
Leki te, nazywane również chemoprewencją, są szczególnie skuteczne u kobiet z atypową hiperplazją. Tamoksyfen wykazał zmniejszenie ryzyka raka piersi o około 50%, a w podgrupie pacjentek z ADH był jeszcze bardziej skuteczny.12
Należy jednak pamiętać, że stosowanie chemoprewencji wiąże się z potencjalnymi działaniami niepożądanymi, takimi jak zakrzepica żył głębokich, zatorowość płucna czy udary. Dlatego konieczna jest indywidualna ocena stosunku korzyści do ryzyka w każdym przypadku.1
Monitorowanie i badania kontrolne
Ze względu na zwiększone ryzyko raka piersi, pacjentki z atypową hiperplazją wymagają ścisłej obserwacji i regularnych badań kontrolnych. Plan monitorowania jest tworzony indywidualnie przez zespół medyczny w oparciu o czynniki ryzyka pacjentki.12
Zalecany protokół monitorowania obejmuje:123
- Kliniczne badanie piersi co 6-12 miesięcy
- Coroczna mammografia z tomosyntezą cyfrową
- Rozważenie corocznego rezonansu magnetycznego (MRI) piersi, szczególnie u pacjentek z wysokim ryzykiem
- Edukacja w zakresie samokontroli piersi
Według National Comprehensive Cancer Network (NCCN), u kobiet z atypową hiperplazją, które mają 20% lub większe ryzyko zachorowania na inwazyjnego raka piersi w ciągu życia, zaleca się:1
- Badanie kliniczne piersi i ocenę ryzyka co 6-12 miesięcy, począwszy od 25 roku życia
- Coroczną mammografię z tomosyntezą piersi, począwszy od 30 roku życia
- Rozważenie corocznego badania MRI piersi, począwszy od 25 roku życia
Intensywne monitorowanie ma na celu wykrycie ewentualnego raka piersi na wczesnym etapie, gdy szanse na wyleczenie są najwyższe.12
Opieka pielęgniarska w procesie monitorowania
Rola pielęgniarki w procesie monitorowania pacjentek z atypową hiperplazją piersi obejmuje:12
- Edukację pacjentki w zakresie konieczności regularnych badań kontrolnych
- Pomoc w organizacji i koordynacji badań przesiewowych
- Instruktaż dotyczący samobadania piersi
- Monitorowanie przestrzegania zaleceń dotyczących farmakoterapii
- Udzielanie wsparcia emocjonalnego i informacyjnego
- Identyfikację i zgłaszanie nowych objawów lub zmian w piersiach
Strategie zmniejszenia ryzyka raka piersi
Oprócz leczenia chirurgicznego i farmakoterapii, pacjentkom z atypową hiperplazją piersi zaleca się wprowadzenie modyfikacji stylu życia, które mogą pomóc w zmniejszeniu ryzyka rozwoju raka piersi.12
Modyfikacje stylu życia
Zalecane modyfikacje stylu życia obejmują:123
- Utrzymanie prawidłowej masy ciała
- Regularna aktywność fizyczna (150-300 minut aktywności o umiarkowanej intensywności lub 75-150 minut aktywności o dużej intensywności tygodniowo)
- Ograniczenie spożycia alkoholu
- Unikanie palenia tytoniu
- Stosowanie diety bogatej w warzywa i owoce, o niskiej zawartości tłuszczów
Badania pokazują, że zdrowy styl życia jest związany ze zmniejszonym ryzykiem inwazyjnego raka piersi, szczególnie u kobiet po menopauzie.1
Unikanie hormonoterapii zastępczej
U pacjentek z atypową hiperplazją piersi zaleca się unikanie hormonoterapii zastępczej stosowanej w leczeniu objawów menopauzy, ponieważ może ona zwiększać ryzyko raka piersi. Jeśli hormonoterapia jest konieczna, powinna być stosowana w najniższej skutecznej dawce przez jak najkrótszy czas.123
Profilaktyczna mastektomia
W przypadkach bardzo wysokiego ryzyka raka piersi, szczególnie gdy występują dodatkowe czynniki ryzyka, takie jak silna rodzinna historia raka piersi lub mutacje genetyczne, zespół medyczny może rozważyć profilaktyczną mastektomię (usunięcie piersi).12
Należy jednak podkreślić, że profilaktyczna mastektomia nie jest rutynowo zalecana wyłącznie z powodu atypowej hiperplazji. Decyzja o tym zabiegu powinna być podejmowana po dokładnej analizie wszystkich czynników ryzyka i dyskusji z zespołem medycznym.1
Wsparcie psychologiczne i edukacja pacjentki
Diagnoza atypowej hiperplazji piersi może być stresująca dla pacjentki ze względu na zwiększone ryzyko raka piersi. Ważne jest, aby zapewnić kompleksowe wsparcie psychologiczne i edukację w celu zmniejszenia lęku i promowania aktywnego udziału w procesie leczenia.12
Wsparcie emocjonalne
Rola pielęgniarki w zapewnieniu wsparcia emocjonalnego obejmuje:1
- Wysłuchanie obaw i lęków pacjentki
- Zapewnienie jasnych i dokładnych informacji na temat schorzenia i ryzyka
- Pomoc w radzeniu sobie ze stresem związanym z diagnozą
- W razie potrzeby skierowanie do specjalisty w zakresie zdrowia psychicznego
- Informowanie o grupach wsparcia i innych zasobach społecznych
Edukacja pacjentki
Kompleksowa edukacja pacjentki powinna obejmować:12
- Wyjaśnienie istoty atypowej hiperplazji i związanego z nią ryzyka raka piersi
- Informacje na temat dostępnych opcji leczenia i monitorowania
- Instrukcje dotyczące samobadania piersi i rozpoznawania niepokojących zmian
- Informacje o chemoprewencji, jej korzyściach i potencjalnych działaniach niepożądanych
- Wskazówki dotyczące modyfikacji stylu życia
- Informacje o znaczeniu regularnych badań kontrolnych
Opieka interdyscyplinarna
Właściwe leczenie pacjentek z atypową hiperplazją piersi wymaga współpracy wielodyscyplinarnego zespołu medycznego. Zespół ten może obejmować:12
- Lekarzy specjalistów (radiologów, chirurgów, patologów, onkologów)
- Pielęgniarki, w tym pielęgniarki specjalistyczne w zakresie zdrowia piersi
- Genetyków klinicznych (w przypadkach podejrzenia predyspozycji genetycznych)
- Psychologów
- Dietetyków
- Zespół podstawowej opieki zdrowotnej
Rola pielęgniarki w zespole interdyscyplinarnym obejmuje koordynację opieki, edukację pacjentki, monitorowanie stanu zdrowia i zapewnienie ciągłości opieki.1
Rokowanie i perspektywy długoterminowe
Atypowa hiperplazja piersi wiąże się z około czterokrotnie zwiększonym ryzykiem rozwoju raka piersi w porównaniu z osobami bez tego schorzenia. Ryzyko to jest największe w okresie 10-15 lat po diagnozie atypowej hiperplazji i zaczyna maleć po 15 latach.12
Ważne jest jednak podkreślenie, że większość osób z atypową hiperplazją nie rozwinie raka piersi. Ryzyko wynosi około 1% rocznie.12
Czynniki, które mogą dodatkowo zwiększać ryzyko raka piersi u osób z atypową hiperplazją, obejmują:12
- Rodzinną historię raka piersi
- Diagnozę atypowej hiperplazji przed menopauzą
- Obecność mutacji genetycznych (np. BRCA1, BRCA2)
- Gęstą tkankę piersi
- Wcześniejsze biopsje piersi
Regularne badania kontrolne, stosowanie się do zaleceń dotyczących farmakoterapii i modyfikacja stylu życia mogą znacznie zmniejszyć ryzyko rozwoju raka piersi u osób z atypową hiperplazją.12
Wnioski i zalecenia dla praktyki pielęgniarskiej
Opieka nad pacjentką z atypową hiperplazją piersi wymaga kompleksowego podejścia, uwzględniającego zarówno aspekty medyczne, jak i psychologiczne. Pielęgniarki odgrywają kluczową rolę w edukacji, wsparciu i koordynacji opieki nad tymi pacjentkami.1
Kluczowe zalecenia dla praktyki pielęgniarskiej obejmują:12
- Szczegółową edukację pacjentki na temat atypowej hiperplazji i związanego z nią ryzyka raka piersi
- Promowanie regularnych badań kontrolnych i monitorowania
- Wsparcie w przestrzeganiu zaleceń dotyczących farmakoterapii
- Zachęcanie do wprowadzenia zdrowego stylu życia
- Zapewnienie wsparcia psychologicznego i emocjonalnego
- Koordynację opieki interdyscyplinarnej
- Regularną ocenę i dokumentację zmian w stanie zdrowia pacjentki
Pielęgniarki powinny również na bieżąco aktualizować swoją wiedzę na temat najnowszych wytycznych i zaleceń dotyczących opieki nad pacjentkami z atypową hiperplazją piersi, aby zapewnić opiekę opartą na dowodach naukowych.12
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Atypical hyperplasia of the breast – Symptoms and causes – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/atypical-hyperplasia/symptoms-causes/syc-20369773
Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. When viewed with a microscope, the cells look different from typical breast cells. […] Atypical hyperplasia of the breast isn’t breast cancer. But it’s a sign that you have an increased risk of breast cancer in the future. […] Your healthcare team creates a plan to help you manage your risk of breast cancer. Often this includes more-frequent breast cancer screening tests. You also might consider medicines to reduce breast cancer risk. […] Atypical hyperplasia of the breast usually doesn’t cause any symptoms. […] Atypical hyperplasia of the breast is typically found during a breast biopsy. A breast biopsy is a procedure to remove some breast cells for testing.
- #1 Atypical hyperplasia of the breast | Beacon Health Systemhttps://www.beaconhealthsystem.org/library/diseases-and-conditions/atypical-hyperplasia-of-the-breast?content_id=CON-20369759
Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. When viewed with a microscope, the cells look different from typical breast cells. […] Atypical hyperplasia of the breast isn’t breast cancer. But it’s a sign that you have an increased risk of breast cancer in the future. […] Your healthcare team creates a plan to help you manage your risk of breast cancer. Often this includes more-frequent breast cancer screening tests. You also might consider medicines to reduce breast cancer risk. […] Atypical hyperplasia can happen in the breast ducts or the breast lobules: Atypical ductal hyperplasia describes a growth of atypical cells within the breast ducts. The breast ducts are tubes that can carry breast milk to the nipple. This type of atypical hyperplasia is most common. Atypical lobular hyperplasia describes a growth of atypical cells within the breast lobules. The breast lobules are glands that can make breast milk. This type of atypical hyperplasia is less common. Both types of atypical hyperplasia increase the risk of breast cancer. Treatment for both types is similar.
- #1 Atypical hyperplasia of the breast – Symptoms and causes – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/atypical-hyperplasia/symptoms-causes/syc-20369773
If you’ve been diagnosed with atypical hyperplasia of the breast, you have an increased risk of getting breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who don’t have atypical hyperplasia. […] Both types of atypical hyperplasia increase the risk of breast cancer. Treatment for both types is similar. […] It’s not clear whether there’s anything that can prevent atypical hyperplasia of the breast. The same things that help lower the risk of breast cancer may help lower the risk of atypical hyperplasia. […] Talk with your doctor or other healthcare professional about when to begin breast cancer screening. […] If there is a new change, a lump or something not typical in your breasts, report it to a healthcare professional right away.
- #1 Atypical hyperplasia of the breast – Hancock Healthhttps://www.hancockhealth.org/mayo-health-library/atypical-hyperplasia-of-the-breast/
Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. When viewed with a microscope, the cells look different from typical breast cells. […] Atypical hyperplasia of the breast is typically found during a breast biopsy. A breast biopsy is a procedure to remove some breast cells for testing. […] Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. In theory, if atypical hyperplasia cells are allowed to continue growing, they could get more DNA changes and become cancer cells. […] Both types of atypical hyperplasia increase the risk of breast cancer. Treatment for both types is similar. […] If you’ve been diagnosed with atypical hyperplasia of the breast, you have an increased risk of getting breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who don’t have atypical hyperplasia.
- #1 Azthena logo with the word Azthenahttps://www.news-medical.net/health/Atypical-Hyperplasia.aspx
Women with a diagnosis of atypical hyperplasia have a higher risk of developing breast cancer in future, than those who do not have the condition. For this reason, intensive breast cancer screening and preventive medications to lower the risk of breast cancer is recommended in these cases. […] Atypical hyperplasia is normally detected during a biopsy to study suspicious areas revealed during routine breast examination or by a mammogram. It is usually diagnosed during a breast biopsy performed in order to investigate the abnormal pattern detected on a mammogram. […] In case atypical hyperplasia is diagnosed, a surgical biopsy may be performed to remove the affected breast tissue. Further evaluation via surgery may be recommended by the doctor and this involves removal of a larger tissue sample from the breast and testing it for the presence of cancerous cells. The larger sample is analyzed by the pathologist for any evidence of invasive or non-invasive cancer.
- #1 Atypical Hyperplasia of the Breast: Follow-up and Management – The ObG Projecthttps://www.obgproject.com/2017/04/19/atypical-hyperplasia-breast-follow-management/
Atypical hyperplasia of the breast is a benign but high-risk condition that can be either ductal (ADH) or lobular (ALH); these occur with equal frequency and together are found in about 10% of breast biopsies. […] Either entity confers a long-term risk of breast cancer that approaches 30% at 25 years of follow-up. […] Surgically excise atypical hyperplasia when found on a core-needle biopsy. […] Necessary to avoid missing invasive cancer due to sampling error. […] DCIS or invasive cancer found in 10 to 20% of cases. […] Current breast cancer risk assessment models perform poorly among women with atypical hyperplasia. […] Atypical hyperplasia associated with a relative risk of approximately 4 for future breast cancer. […] Follow-up screening recommendations include annual mammography, breast awareness, and clinical encounter every 6 to 12 months.
- #1 CE Activity | Atypical Breast Hyperplasia | Nurseshttps://www.statpearls.com/nurse/ce/activity/100465/?specialty=Nurse%20-%20Breast%20Care%20CBCN%C2%A9%20Review
Atypical hyperplasia of the breast is defined as abnormal epithelial proliferative breast lesions that are not qualitatively or quantitatively abnormal enough to be classified as carcinoma in situ. Atypical hyperplasia is a premalignant condition and may occur in either ductal or lobular epithelium. This activity describes the evaluation, surveillance, and management of atypical breast hyperplasia and highlights the role of the interprofessional team in the care of affected patients. […] At the conclusion of this activity, the learner will be better able to: […] Explain the management of atypical breast hyperplasia. […] Review the surveillance protocol for patients with atypical breast hyperplasia. […] Summarize a structured interprofessional team approach to provide effective care to and appropriate surveillance of patients with atypical breast hyperplasia.
- #1 Atypical hyperplasia of the breast – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/atypical-hyperplasia/diagnosis-treatment/drc-20369778
Atypical hyperplasia of the breast is most often diagnosed during a breast biopsy. […] Treatment for atypical hyperplasia of the breast may involve surgery to remove the atypical cells. […] Atypical hyperplasia of the breast may be treated with surgery to remove the atypical cells. […] Not everyone with atypical hyperplasia of the breast needs surgery. […] Medicines that block the hormone estrogen in the body can lower the risk of breast cancer. […] Atypical hyperplasia of the breast increases the risk of breast cancer. […] Your healthcare team creates a breast cancer screening plan. […] To reduce your risk of breast cancer, your healthcare team may recommend that you avoid hormone therapy for menopause. […] If you have a very high risk of breast cancer, your healthcare team might recommend surgery to lower your risk.
- #1 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/sites/books/n/statpearls/article-17992/
Atypical hyperplasia of the breast is defined as abnormal epithelial proliferative breast lesions that are not qualitatively or quantitatively abnormal enough to be classified as carcinoma in situ. Atypical hyperplasia is a premalignant condition and may occur in either ductal or lobular epithelium. This activity describes the evaluation, surveillance, and management of atypical breast hyperplasia and highlights the role of the interprofessional team in the care of affected patients. […] Atypical hyperplasia lesions are pre-malignant. Many authorities believe the patient should undergo complete surgical excision to exclude malignancy and prevent the development of advanced neoplasia if found on a breast biopsy. Surgical excision for core biopsies that show ADH is considered standard of care. However, ALH may be an incidental finding in small biopsies, and standard surgical resection of these lesions is more controversial. In general, excision is usually recommended in high-risk patients.
- #1 Atypical hyperplasia of the breast – Hancock Healthhttps://www.hancockhealth.org/mayo-health-library/atypical-hyperplasia-of-the-breast/
Treatment for atypical hyperplasia of the breast may involve surgery to remove the atypical cells. Not everyone needs surgery. Your healthcare team might recommend more-frequent breast cancer screening to watch for signs of breast cancer. You also might consider medicine to lower your risk of breast cancer. […] Atypical hyperplasia of the breast increases the risk of breast cancer. So your healthcare team creates a breast cancer screening plan. You might have more-frequent screening or different screening tests than would someone with an average risk of breast cancer. […] Medicines that block the hormone estrogen in the body can lower the risk of breast cancer. Most breast cancers use estrogen and other hormones to help the cancer grow. Blocking estrogen helps stop cancer from forming.
- #1 Atypical Hyperplasia | Memorial Sloan Kettering Cancer Centerhttps://www.mskcc.org/cancer-care/patient-education/atypical-hyperplasia
Your breast is made of ducts and lobules. Hyperplasia is a condition where there are more cells than usual in your breast ducts or lobules. In atypical hyperplasia the extra cells look different from normal breast cells. […] ADH isn’t cancer, but it may raise your risk of getting breast cancer in the future. […] ALH is linked to a higher risk of getting breast cancer. […] Because of the increased breast cancer risk, people with either type of atypical hyperplasia should get regular breast exams and breast imaging tests. […] Taking certain medications can help lower your risk of getting breast cancer. […] Tamoxifen and raloxifene are medications that lower your risk for breast cancer. […] Aromatase inhibitors are medications that stop an enzyme called aromatase from changing other hormones into estrogen.
- #1 Alaska Breast Care & Surgery-Atypical Hyperplasiashttp://www.alaskabreastcare.com/atypicalhyperplasias.html
Life style modifications are always important. Breast cancer risk reduction medications are particularly useful in this group of patients. […] Tamoxifen has been shown to decrease the risk of breast cancer by about 50%. However, in the subset of patients who had ADH, Tamoxifen was even more effective. […] There are other forms of atypia that can show up on a biopsy report including atypical lobular hyperplasia, flat epithelial atypia and columnar cell change with atypia. All seem to increase the future risk of getting breast cancer.
- #1 Atypical Hyperplasia Treatment | New England Breast And Wellnesshttps://www.nebreastandwellness.com/treatments/atypical-hyperplasia-treatment/
Once atypical hyperplasia is diagnosed on a core biopsy, the doctor may recommend an excisional biopsy to examine the surrounding breast tissues. This ensures that atypical hyperplasia isnt symptomatic of a deeper problem or existing breast cancer. The doctor will curate a treatment plan based on the size and severity of the condition. […] Youll be placed on a close follow-up program for high-risk women if youre diagnosed with atypical hyperplasia and have a family history of breast cancer. The follow-up program includes clinical breast exams once every six months and annual mammograms. Your doctor may also recommend various medications for breast cancer prevention (chemoprevention), such as tamoxifen and raloxifene. […] Chemoprevention may increase the risk of numerous side effects, such as pulmonary embolism (blood clots in the lungs), deep vein thrombosis (blood clots in veins), and strokes. While the risk is relatively small, it shouldnt be ignored. Thats why you should determine if you want to start chemoprevention after weighing the risks and benefits with your doctor.
- #1 Breast Cancer Risk: Usual and Atypical Hyperplasia | Susan G. Komen®https://www.komen.org/breast-cancer/risk-factor/hyperplasia-and-other-benign-breast-conditions/
With atypical hyperplasia, the proliferating (dividing) cells look abnormal. […] Women with atypical hyperplasia have about 3 to 5 times the breast cancer risk of women without a proliferative breast condition. […] For women with atypical hyperplasia who also have a 20% or greater lifetime risk of invasive breast cancer, there are special breast cancer screening recommendations. […] The National Comprehensive Cancer Network (NCCN) recommends women with atypical hyperplasia who also have a 20% or greater lifetime risk of invasive breast cancer: Have a clinical breast exam and risk assessment every 6-12 months, starting by age 25; Have a mammogram with digital breast tomosynthesis every year, starting at age 30; Talk with a health care provider about screening with breast MRI every year, starting at age 25.
- #1 Breast Cancer Risk: Usual and Atypical Hyperplasia | Susan G. Komen®https://www.komen.org/breast-cancer/risk-factor/hyperplasia-and-other-benign-breast-conditions/
Screening helps make sure if breast cancer does develop, its caught early when the chances of survival are highest. […] The NCCN strongly recommends women with atypical hyperplasia take a risk-reducing drug (such as tamoxifen) to lower their risk of developing breast cancer. […] These drugs can lower the risk of breast cancer in women with atypical hyperplasia by about 86%.
- #1 Atypical hyperplasia of the breast: Clinical cases and management strategies | Cleveland Clinic Journal of Medicinehttps://www.ccjm.org/content/90/7/423
Risk-reducing endocrine therapy should be discussed with patients because of increased lifetime risk of breast cancer, estimated at 1% per year. […] Risk-reducing endocrine therapy should be discussed with patients who have ALH. […] A healthy lifestyle is associated with a reduced risk for invasive breast cancer, especially in postmenopausal women. […] Current American Cancer Society guidelines recommend achieving and maintaining a healthy weight and limiting alcohol intake and avoiding smoking to reduce cancer risk. Individually tailored whole foods, plant-based dietary patterns, and 150 to 300 minutes of moderate intensity or 75 to 150 minutes of vigorous intensity activity each week (or a combination of these) also reduce breast cancer risk.
- #1 Atypical hyperplasia of the breast – Symptoms and causes – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/atypical-hyperplasia/symptoms-causes/syc-20369773
Hormone therapy treatments used to ease menopause symptoms may increase the risk of breast cancer. Talk with a healthcare professional about the benefits and risks of hormone therapy. […] To reduce the risk of breast cancer, use the lowest dose of hormone therapy possible for the shortest amount of time.
- #1 Atypical Hyperplasia – Tower Love Fund – Breast Cancer Explainedhttps://www.towercancer.org/resource/breast-cancer-explained/atypical-hyperplasia/
If you have a family history of breast cancer in addition to ADH or ALH and you want to understand more about whether your family history may contribute to your breast cancer risk, you should make an appointment with a genetic counselor to discuss testing for the hereditary breast cancer gene mutations, called BRCA1 and BRCA2, which put women at higher risk for breast and ovarian cancer. […] The surgery is only recommended if you have a strong family history of the disease. It is not recommended for women just because they have had a diagnosis of atypical hyperplasia.
- #1 Atypical hyperplasia of the breasthttps://www.mymlc.com/health-information/diseases-and-conditions/a/atypical-hyperplasia-of-the-breast2/?section=Causes
To reduce your risk of developing breast cancer, your doctor may recommend that you: Take preventive medications. Treatment with a selective estrogen receptor modulator, such as tamoxifen or raloxifene (Evista), for five years may reduce the risk of breast cancer. […] An atypical hyperplasia diagnosis can be stressful, since it increases your risk of breast cancer. Not knowing what the future holds may make you fearful for your health. […] If youâve been diagnosed with atypical hyperplasia, your doctor may recommend more-frequent breast cancer screening exams and tests.
- #1 Atypical ductal hyperplasia: What it is and how it’s treated | MD Anderson Cancer Centerhttps://www.mdanderson.org/cancerwise/atypical-ductal-hyperplasia–what-it-is-and-how-to-treat-it.h00-159695967.html
Atypical ductal hyperplasia is not cancer, but it does put you at a greater risk of developing breast cancer. […] If the biopsy just shows atypical ductal hyperplasia and no cancer, we refer the patient for high-risk breast screening, which can include annual mammograms and breast MRIs. Patients will also learn about risk-reducing medications, sometimes called chemoprevention. […] MD Andersons High Risk Breast Screening and Genetics Clinic provides patients with breast cancer screening, risk-reducing medication counseling and genetic risk evaluation. The care is personalized for each patient. Your care team will help determine the best treatment plan for you. […] It’s important to understand your risk for breast cancer. So, make sure you speak with your health care provider about whether you need genetic testing as well as ways to help reduce your chances of getting breast cancer.
- #1 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/sites/books/n/statpearls/article-17992/
Proper management of patients with this complex disease requires collaboration between radiology, surgery, pathology, and the patient and their primary care team. The current standard of care is to excise high-risk breast lesions due to high upgrade rates on the excision of these breast lesions after a biopsy.
- #1 Atypical hyperplasia of the breast | Canadian Cancer Societyhttps://cancer.ca/en/cancer-information/cancer-types/breast/what-is-breast-cancer/non-cancerous-conditions/atypical-hyperplasia
Having atypical hyperplasia increases the risk for breast cancer. This risk is even higher in women who have a family history of breast cancer or who are diagnosed with atypical hyperplasia before they reach menopause. Breast cancer is more likely to start in the breast where atypical hyperplasia is found. The risk of developing breast cancer is greatest 10-15 years after atypical hyperplasia is diagnosed. The risk begins to go down after 15 years. […] Women with atypical hyperplasia should talk to their doctor about a personal plan of testing for breast cancer, including regular mammography. […] You may be offered chemoprevention if you have atypical hyperplasia of the breast, especially if you have a family history of breast cancer. The drugs used are called selective estrogen-receptor modulators (SERMs) because they block the effects of estrogen in breast tissue: […] Women with atypical hyperplasia should talk to their healthcare team about the benefits and possible risks of taking SERMs to reduce their risk of breast cancer.
- #1 Atypical Hyperplasia of the Breast | CommonSpirit Healthhttps://www.commonspirit.org/conditions-treatments/atypical-hyperplasia-of-the-breast
Atypical hyperplasia may be treated by removing the abnormal cells. These may be removed during the breast biopsy. But in some cases, the doctor may make a small cut in the skin to take out more breast tissue. […] You will work with your doctor to reduce your risk of breast cancer. You may have a breast exam every 6 months and a mammogram once a year. Your doctor may suggest that you have an MRI scan of the breast. […] Take your medicines exactly as prescribed. Have follow-up testing as often as your doctor recommends. Talk to your doctor about ways to reduce your risk of cancer. These may include being active, limiting alcohol, not smoking, eating healthy foods, and staying at a weight that is healthy for you.
- #2 Atypical hyperplasia of the breast | Beacon Health Systemhttps://www.beaconhealthsystem.org/library/diseases-and-conditions/atypical-hyperplasia-of-the-breast?content_id=CON-20369759
Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. When viewed with a microscope, the cells look different from typical breast cells. […] Atypical hyperplasia of the breast isn’t breast cancer. But it’s a sign that you have an increased risk of breast cancer in the future. […] Your healthcare team creates a plan to help you manage your risk of breast cancer. Often this includes more-frequent breast cancer screening tests. You also might consider medicines to reduce breast cancer risk. […] Atypical hyperplasia can happen in the breast ducts or the breast lobules: Atypical ductal hyperplasia describes a growth of atypical cells within the breast ducts. The breast ducts are tubes that can carry breast milk to the nipple. This type of atypical hyperplasia is most common. Atypical lobular hyperplasia describes a growth of atypical cells within the breast lobules. The breast lobules are glands that can make breast milk. This type of atypical hyperplasia is less common. Both types of atypical hyperplasia increase the risk of breast cancer. Treatment for both types is similar.
- #2 Atypical Hyperplasia Treatment | New England Breast And Wellnesshttps://www.nebreastandwellness.com/treatments/atypical-hyperplasia-treatment/
Once atypical hyperplasia is diagnosed on a core biopsy, the doctor may recommend an excisional biopsy to examine the surrounding breast tissues. This ensures that atypical hyperplasia isnt symptomatic of a deeper problem or existing breast cancer. The doctor will curate a treatment plan based on the size and severity of the condition. […] Youll be placed on a close follow-up program for high-risk women if youre diagnosed with atypical hyperplasia and have a family history of breast cancer. The follow-up program includes clinical breast exams once every six months and annual mammograms. Your doctor may also recommend various medications for breast cancer prevention (chemoprevention), such as tamoxifen and raloxifene. […] Chemoprevention may increase the risk of numerous side effects, such as pulmonary embolism (blood clots in the lungs), deep vein thrombosis (blood clots in veins), and strokes. While the risk is relatively small, it shouldnt be ignored. Thats why you should determine if you want to start chemoprevention after weighing the risks and benefits with your doctor.
- #2 Atypical hyperplasia of the breast | UM Health-Sparrowhttps://www.uofmhealthsparrow.org/departments-conditions/conditions/atypical-hyperplasia-breast
Treatment for atypical hyperplasia of the breast may involve surgery to remove the atypical cells. Not everyone needs surgery. Your healthcare team might recommend more-frequent breast cancer screening to watch for signs of breast cancer. You also might consider medicine to lower your risk of breast cancer. […] Atypical hyperplasia of the breast increases the risk of breast cancer. So your healthcare team creates a breast cancer screening plan. You might have more-frequent screening or different screening tests than would someone with an average risk of breast cancer. […] To reduce your risk of breast cancer, your healthcare team may recommend that you: Avoid hormone therapy for menopause. […] If you have atypical hyperplasia of the breast, a breast health specialist can help you understand your breast cancer risk and create a plan to help you manage the risk.
- #2 Atypical hyperplasia of the breast – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/atypical-hyperplasia/diagnosis-treatment/drc-20369778
Atypical hyperplasia of the breast is most often diagnosed during a breast biopsy. […] Treatment for atypical hyperplasia of the breast may involve surgery to remove the atypical cells. […] Atypical hyperplasia of the breast may be treated with surgery to remove the atypical cells. […] Not everyone with atypical hyperplasia of the breast needs surgery. […] Medicines that block the hormone estrogen in the body can lower the risk of breast cancer. […] Atypical hyperplasia of the breast increases the risk of breast cancer. […] Your healthcare team creates a breast cancer screening plan. […] To reduce your risk of breast cancer, your healthcare team may recommend that you avoid hormone therapy for menopause. […] If you have a very high risk of breast cancer, your healthcare team might recommend surgery to lower your risk.
- #2 Learning About Atypical Hyperplasia of the Breast | Kaiser Permanentehttps://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.learning-about-atypical-hyperplasia-of-the-breast.acf2776
Atypical hyperplasia may be treated by removing the abnormal cells. These may be removed during the breast biopsy. […] Your doctor may have you take medicines to help prevent breast cancer. These may include tamoxifen. If you are past menopause, the medicines may also include aromatase inhibitors. […] You will work with your doctor to reduce your risk of breast cancer. You may have a breast exam every 6 months and a mammogram once a year. Your doctor may suggest that you have an MRI scan of the breast. […] Follow-up care is a key part of your treatment and safety. Be sure to make and go to all appointments, and call your doctor if you are having problems. It’s also a good idea to know your test results and keep a list of the medicines you take.
- #2 Atypical Hyperplasia of the Breast: Follow-up and Management – The ObG Projecthttps://www.obgproject.com/2017/04/19/atypical-hyperplasia-breast-follow-management/
Also consider annual MRI to begin at diagnosis. […] Based on emerging evidence, ACOG also recommends consideration of yearly breast MRI for atypical hyperplasia. […] Encourage pharmacologic risk reduction with either a selective estrogen-receptor modulator (SERM) or an aromatase inhibitor (AI) for prevention of breast cancer. […] Counsel about healthy lifestyle including ideal body weight and alcohol reduction. […] Atypical hyperplasia is generally not an indication for surgical risk-reduction / mastectomy.
- #2 Breast Cancer Risk: Usual and Atypical Hyperplasia | Susan G. Komen®https://www.komen.org/breast-cancer/risk-factor/hyperplasia-and-other-benign-breast-conditions/
Screening helps make sure if breast cancer does develop, its caught early when the chances of survival are highest. […] The NCCN strongly recommends women with atypical hyperplasia take a risk-reducing drug (such as tamoxifen) to lower their risk of developing breast cancer. […] These drugs can lower the risk of breast cancer in women with atypical hyperplasia by about 86%.
- #2 Breast Hyperplasia: Is It Cancer? Can It Lead to Cancer?https://www.rockymountaincancercenters.com/blog/breast-hyperplasia-is-it-cancer-can-it-lead-to-cancer
While hyperplasia is not cancer, it does mean you should create a breast cancer screening plan with your doctor that takes into account that this area needs to be monitored. […] The risk of breast cancer increases by 4-5 times for atypical breast hyperplasia compared to women without breast conditions. […] Atypical hyperplasia is found in about 10% of breast biopsies that are evaluating non-cancerous breast conditions. […] Breast hyperplasia is not cancer. However, it increases your risk of developing cancer in the future by four times more than a person without hyperplasia. […] Surgery is sometimes an option for women with atypical hyperplasia so that additional breast tissue can be removed from the area around where the biopsy was performed. […] Regardless of whether its usual or atypical breast hyperplasia, or whether surgery was performed, additional screening and self-monitoring are important. […] You may be able to slow or stop the transition of atypical breast hyperplasia into estrogen-positive breast cancer by taking estrogen-blocking medication. […] Taking extra precautions after a diagnosis of breast hyperplasia is smart. Its the best way to lower your risk of future breast cancer.
- #2 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/sites/books/n/statpearls/article-17992/
Proper management of patients with this complex disease requires collaboration between radiology, surgery, pathology, and the patient and their primary care team. The current standard of care is to excise high-risk breast lesions due to high upgrade rates on the excision of these breast lesions after a biopsy.
- #2 Atypical hyperplasia of the breast – Hancock Healthhttps://www.hancockhealth.org/mayo-health-library/atypical-hyperplasia-of-the-breast/
If you have a very high risk of breast cancer, your healthcare team might recommend surgery to lower your risk. […] To reduce your risk of breast cancer, your healthcare team may recommend that you make healthy choices in your daily life to reduce your risk of breast cancer. For instance, exercise most days of the week and maintain a healthy weight. […] If a mammogram reveals a suspicious area in your breast, your healthcare professional may refer you to a breast health specialist or a specialized breast center. If you have atypical hyperplasia of the breast, a breast health specialist can help you understand your breast cancer risk and create a plan to help you manage the risk.
- #2 Navigating breast health: a comprehensive approach to atypical ductal hyperplasia of the breast management and surveillancehttps://www.explorationpub.com/Journals/em/Article/1001205
Risk reduction strategies include lifestyle modifications such as healthy diet, regular aerobic exercise, maintaining ideal body weight, and avoidance of smoking and alcohol consumption. […] The vast majority of ADH is estrogen receptor positive and adjuvant endocrine therapy with selective estrogen receptor modulators (SERMs) such as tamoxifen and raloxifene or aromatase inhibitors (AIs) such as anastrozole and exemestane, is offered to patients who are diagnosed with ADH of the breast. […] Due to the high lifetime risk of breast cancer, all patients diagnosed with ADH should be offered lifelong clinical surveillance with clinical breast examination every 612 months, annual diagnostic MMO with tomography, and enhanced surveillance with annual MRI.
- #2 Atypical hyperplasia of the breast | Beacon Health Systemhttps://www.beaconhealthsystem.org/library/diseases-and-conditions/atypical-hyperplasia-of-the-breast?content_id=CON-20369759
To reduce your risk of breast cancer, your healthcare team may recommend that you: Avoid hormone therapy for menopause. Certain kinds of medicines that use hormones to help control symptoms of menopause can increase the risk of breast cancer. […] If you have atypical hyperplasia of the breast, a breast health specialist can help you understand your breast cancer risk and create a plan to help you manage the risk.
- #2 Atypical Hyperplasia | Memorial Sloan Kettering Cancer Centerhttps://www.mskcc.org/cancer-care/patient-education/atypical-hyperplasia
Some people may choose to have their breasts removed to prevent breast cancer. This is called a bilateral prophylactic mastectomy. This surgery is sometimes used to lower the risk of breast cancer in people with ADH or ALH. […] There are also lifestyle changes you can make to lower your breast cancer risk if you have LCIS.
- #2 Atypical hyperplasia of the breast | Altru Health Systemhttps://www.altru.org/health-library/conditions/atypical-hyperplasia-of-the-breast
Finding out that you have atypical hyperplasia of the breast can feel stressful. […] If a mammogram reveals a suspicious area in your breast, your healthcare professional may refer you to a breast health specialist or a specialized breast center. […] Your healthcare team is likely to ask you a number of questions. Be prepared to answer questions such as: Do you have a family history of breast cancer?
- #2 Atypical Hyperplasia Underestimated Marker for Breast Cancerhttps://www.medscape.org/viewarticle/838990
Clinicians should consider having patients with atypical hyperplasia undergo an annual breast magnetic resonance imaging (MRI) screening, in addition to an annual mammogram, the authors suggest. […] Guidelines need to be updated to include annual MRI screening for this atypical hyperplasia population, they add. […] The other broad recommendation from the authors is that patients with atypical hyperplasia be offered chemopreventive agents. […] The authors of this special report argue that education be provided to women with atypical hyperplasia regarding the related risk for breast cancer, as well as chemoprevention options and the anticipated reduction in risk and the risks for various adverse effects. […] American Society of Clinical Oncology guidelines state that for women with a 5-year projected absolute risk for breast cancer of 1.7% or higher, „the use of a chemopreventive agent should be discussed,” say the report authors.
- #2 Atypical ductal hyperplasia: What it is and how it’s treated | MD Anderson Cancer Centerhttps://www.mdanderson.org/cancerwise/atypical-ductal-hyperplasia–what-it-is-and-how-to-treat-it.h00-159695967.html
Atypical ductal hyperplasia is not cancer, but it does put you at a greater risk of developing breast cancer. […] If the biopsy just shows atypical ductal hyperplasia and no cancer, we refer the patient for high-risk breast screening, which can include annual mammograms and breast MRIs. Patients will also learn about risk-reducing medications, sometimes called chemoprevention. […] MD Andersons High Risk Breast Screening and Genetics Clinic provides patients with breast cancer screening, risk-reducing medication counseling and genetic risk evaluation. The care is personalized for each patient. Your care team will help determine the best treatment plan for you. […] It’s important to understand your risk for breast cancer. So, make sure you speak with your health care provider about whether you need genetic testing as well as ways to help reduce your chances of getting breast cancer.
- #2 Atypical Hyperplasia of the Breast: Follow-up and Management – The ObG Projecthttps://www.obgproject.com/2017/04/19/atypical-hyperplasia-breast-follow-management/
Atypical hyperplasia of the breast is a benign but high-risk condition that can be either ductal (ADH) or lobular (ALH); these occur with equal frequency and together are found in about 10% of breast biopsies. […] Either entity confers a long-term risk of breast cancer that approaches 30% at 25 years of follow-up. […] Surgically excise atypical hyperplasia when found on a core-needle biopsy. […] Necessary to avoid missing invasive cancer due to sampling error. […] DCIS or invasive cancer found in 10 to 20% of cases. […] Current breast cancer risk assessment models perform poorly among women with atypical hyperplasia. […] Atypical hyperplasia associated with a relative risk of approximately 4 for future breast cancer. […] Follow-up screening recommendations include annual mammography, breast awareness, and clinical encounter every 6 to 12 months.
- #2 Proliferative Breast Disease with Atypia | Dr. Garvithttps://drgarvitchitkara.com/blogs/managing-proliferative-breast-disease-with-atypia/
Most people with proliferative breast disease without atypia proliferative breast disease with atypia do not develop breast cancer, despite their risk being higher than that of the general population. However, diligent observation and follow-up care are necessary to find any changes or potential advancement. […] If you are concerned about the implications of Proliferative breast disease with atypia, please speak with a cancer specialist like Dr. Garvit Chitkara. He will work with you to create a custom care plan based on your unique risk factors and medical background.
- #2 Atypical Hyperplasia – Tower Love Fund – Breast Cancer Explainedhttps://www.towercancer.org/resource/breast-cancer-explained/atypical-hyperplasia/
If you have a family history of breast cancer in addition to ADH or ALH and you want to understand more about whether your family history may contribute to your breast cancer risk, you should make an appointment with a genetic counselor to discuss testing for the hereditary breast cancer gene mutations, called BRCA1 and BRCA2, which put women at higher risk for breast and ovarian cancer. […] The surgery is only recommended if you have a strong family history of the disease. It is not recommended for women just because they have had a diagnosis of atypical hyperplasia.
- #2 Atypical Hyperplasia Underestimated Marker for Breast Cancerhttps://www.medscape.org/viewarticle/838990
„Women with atypical hyperplasia clearly meet this risk criterion,” they write. […] The current review by Hartmann and colleagues recommends that women with a history of atypical hyperplasia be considered for MRI breast screening and treatment with a SERM or aromatase inhibitor to prevent breast cancer.
- #3 Atypical hyperplasia of the breast // Middlesex Healthhttps://middlesexhealth.org/learning-center/diseases-and-conditions/atypical-hyperplasia-of-the-breast
Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. When viewed with a microscope, the cells look different from typical breast cells. […] Atypical hyperplasia of the breast isn’t breast cancer. But it’s a sign that you have an increased risk of breast cancer in the future. […] Your healthcare team creates a plan to help you manage your risk of breast cancer. Often this includes more-frequent breast cancer screening tests. You also might consider medicines to reduce breast cancer risk. […] Atypical hyperplasia of the breast usually doesn’t cause any symptoms. […] Atypical hyperplasia of the breast is typically found during a breast biopsy. […] If you’ve been diagnosed with atypical hyperplasia of the breast, you have an increased risk of getting breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who don’t have atypical hyperplasia.
- #3 Atypical hyperplasia of the breast | Health Library | Memorial Health Systemhttps://www.mhsystem.org/health-library/con-20369759/
Atypical hyperplasia of the breast may be treated with surgery to remove the atypical cells. This might be recommended if mammogram images show something concerning. Members of your healthcare team typically decide whether to recommend surgery based on a discussion of your imaging test results, the results of your breast biopsy and other factors. […] If you have surgery, the tissue removed during the operation is tested in the lab to look for signs of cancer. Most people who have surgery for atypical hyperplasia dont have breast cancer. But sometimes the surgery finds noninvasive breast cancer, also called ductal carcinoma in situ, or invasive breast cancer. […] Not everyone with atypical hyperplasia of the breast needs surgery. Some healthcare teams may not recommend surgery if there is a low risk of finding cancer. The level of risk may depend on the findings of your mammogram images and other factors, such as your medical history and past breast operations. Your healthcare team carefully considers your biopsy results and your other health conditions when choosing the treatment plan thats best for you.
- #3 Azthena logo with the word Azthenahttps://www.news-medical.net/health/Atypical-Hyperplasia-and-Breast-Cancer-Risk.aspx
Atypical hyperplasia is described as an accumulation of abnormal cells in the breast. It is not cancer, but can be a pre-cancerous condition. In other words, the abnormal cells that cause atypical hyperplasia keep dividing and piling up, and may eventually result in non-invasive or invasive breast cancer. […] Women diagnosed with atypical hyperplasia are at 4 times higher risk of breast cancer than women without it. This remains the same whether the atypical hyperplasia is seen in the ducts or within the lobules. […] Special breast cancer screening recommendations are in place for women diagnosed with atypical hyperplasia. These are intended to help in catching the development of breast cancer, if any, at an early stage, when it can be treated easily and successfully. […] According to National Comprehensive Cancer Network (NCCN) recommendations, women with atypical hyperplasia should have a clinical breast examination every 6 to 12 months after 30 years of age, and have a mammogram once a year starting at age 30 years. […] Women having atypical hyperplasia can be treated with drugs that reduce their risk of developing breast cancer. Tamoxifen and raloxifene are the 2 main FDA-approved drugs used in such cases, both of which are taken in pill form.
- #3 Navigating breast health: a comprehensive approach to atypical ductal hyperplasia of the breast management and surveillancehttps://www.explorationpub.com/Journals/em/Article/1001205
Risk reduction strategies include lifestyle modifications such as healthy diet, regular aerobic exercise, maintaining ideal body weight, and avoidance of smoking and alcohol consumption. […] The vast majority of ADH is estrogen receptor positive and adjuvant endocrine therapy with selective estrogen receptor modulators (SERMs) such as tamoxifen and raloxifene or aromatase inhibitors (AIs) such as anastrozole and exemestane, is offered to patients who are diagnosed with ADH of the breast. […] Due to the high lifetime risk of breast cancer, all patients diagnosed with ADH should be offered lifelong clinical surveillance with clinical breast examination every 612 months, annual diagnostic MMO with tomography, and enhanced surveillance with annual MRI.
- #3 Atypical Lobular Hyperplasia and Risk of Breast Cancerhttps://www.verywellhealth.com/atypical-lobular-hyperplasia-of-the-breast-430684
Atypical lobular hyperplasia (ALH) is a precancerous condition that could lead to the earliest stage of breast cancer, known as ductal carcinoma in situ (DCIS). […] Because the risk of cancer is increased if you have ALH, you would need to undergo routine breast cancer screening. […] Many cases of ALH do not require treatment and will instead be monitored regularly to check for any changes in breast tissues. This is called active surveillance. […] Some people at high risk of breast cancer may have the ALH lesions removed just to be safe. […] It is difficult to predict which cases of ALH will remain benign and which may turn cancerous, so surveillance is essential. […] Breast cancer risk-reduction strategies are also advised, including keeping a healthy weight, quitting cigarettes, staying physically active, avoiding alcohol, and eating a low-fat diet. […] For some, medication such as tamoxifen and raloxifene may reduce the risk of breast cancer by up to 70%. […] ALH often does not require treatment but will instead be regularly monitored with a screening mammogram and/or a breast MRI.
- #3 Atypical Lobular Hyperplasia | Tampa General Hospitalhttps://www.tgh.org/institutes-and-services/conditions/atypical-lobular-hyperplasia-alh
Atypical lobular hyperplasia (ALH) is a precancerous condition that develops when breast tissue cells undergo abnormal changes that affect their size, shape, appearance and growth patterns. […] Although atypical lobular hyperplasia is a benign condition, women with this diagnosis are three to five times more likely to develop breast cancer in the future. […] Tampa General Hospitals renowned Breast Cancer Center offers the latest options for diagnosing atypical lobular hyperplasia and early-stage breast cancer. […] Because atypical lobular hyperplasia increases the risk of breast cancer, it is generally treated with surgery to remove the abnormal tissue and confirm that there is no in situ or invasive cancer in the area. […] A physician may also recommend more frequent breast cancer screenings, including clinical breast exams, mammograms and magnetic resonance imaging (MRI) scans, and possibly preventive medication. […] Additionally, because many breast cancers grow in response to hormone exposure, women with ALH are advised to avoid hormone therapy after menopause.